Navigation Links
Patients Will Suffer Under PBS Cost Recovery

AMA President, Dr Mukesh Haikerwal, today warned that patients would bear the brunt of a Government proposal to recover Pharmaceutical Benefits Scheme (PBS) costs from pharmaceutical manufacturers.

This plan would very likely push up the costs of vital drugs, leaving those who can least afford to pay for their medication facing a greater financial burden, Dr Haikerwal said.

The PBS is very important it ensures that Australians are able to access the medicines they need, regardless of their own personal financial circumstances.

The AMA vigorously opposes any move to weaken that.

The AMA Federal Council yesterday passed an urgency motion stating there is no case for recovering the cost of PBS listing and pricing functions of the Department of Health and Ageing from the pharmaceutical industry.

Widespread public benefits flow from the PBS listing and pricing decisions, Dr Haikerwal said.

Cost recovery would be economically inefficient, and would ultimately weaken the independence and impartiality of the PBS to the detriment of the Australian people.

It is inevitable that drug companies will push up the prices of medicine to recover the additional costs.

The AMA calls on the Federal Government to abandon its plans to introduce this measure.

PBS cost recovery from the pharmaceutical industry is due to be introduced in July next year.


'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:10/7/2008)...t in post-HAART era , , TUESDAY, Oct. 7 ...earch finds little evidence that circumcision prot...ut the issue is still far from settled. , For o...werful AIDS drugs showed that circumcision did hav...nched the most definitive type of research into th...
(Date:10/7/2008)...ter at the University of California, San Diego (UC...less march of advanced lung cancer by treating pat...any vaccines attempt to pump up the immune system ...s genetically engineered to also trick the cancer ...ivities. , The first patients have begun enrolli...
(Date:10/7/2008)...quest comes at stem cell symposium, ANN ARBOR, Mi...ne year,ago, retail pioneer A. Alfred Taubman anno...igan, to endow a new research institute aimed at,u...e., Today, at the institute,s first symposium, he...an additional $22 million to the,University for th...
(Date:10/7/2008)...E NATION HAVE SAID ,I VOTE FOR THE ...ire/ -- To aid and help educate tonight,s debate,w...idential candidates,Senators John McCain and Barac...Susan G. Komen for the Cure(R) Advocacy Alliance t...ts web site --, http://www.IVotefortheCure.org ., ...
Breaking Medicine News(10 mins):Health News:Role of Circumcision in Reducing HIV Risk Still Unclear 2Health News:Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center 2Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3
...vidence to implicate insulin-like growth factor re...ase.// In a previous research, Terry J. Smith, M.... the interaction between immunoglobulins and IGF-1...ocyte infiltration in both Graves’ disease and rhe...
...ind a cure for deafness. As a leader in stem cell-...iversity School of Medicine,// he's got a step-by-... take another decade or so, but if anyone can do i...ur bets on. 'Everyone asks, 'How long before we d...
...tion of East Caribbean States (OECS) have said sch...ntion studies to their respective curricula. Arse... pandemic has raised concern of great magnitude in...tistics, the year 2006 saw 170,000 new cases of in...
...ally Administered Tribal Area (FARA) was the secon...t the immunization //drive carried out by the gove... chief surgeon at the main government hospital in ...olled roadside bomb exploded in Salarzai, a villag...
Other Medicine News:Health News:A Single Biological Mechanism Behind Several Autoimmune Disorders 2Health News:Stem Cell Transplants Explored as a Possible Treatment for Hearing Loss 2
(Date:10/7/2008)...tCall/ -- CEL-SCI Corporation,(NYSE: CVM ) announ...sfer,Agreement (MTA) with the National Institutes ...ry of Dr. Francesco M. Marincola, M.D., to,investi...icroenvironment,caused by CEL-SCI,s cancer drug Mu...ous Disease and Immunogentics Section, Department ...
(Date:10/7/2008).../ -- Aerovance Inc. today reported,pharmacokinetic...Aerovant,inhalation powder that demonstrate good t...llowing asthma patients, inhalation of a single 10... three doses investigated in,Aerovance,s Phase IIb...arly,next year. Evidence gathered from nonclinical...
(Date:10/7/2008)... Tests for Use on the GeneXpert(R) ...7 /- Cepheid (Nasdaq:,CPHD)...B as a European CE,IVD Mark product under the Euro...ces. The test delivers rapid detection of vanA and... with vancomycin-resistant,enterococci (VRE) -- on...
(Date:10/6/2008)...e/ -- "A return to the use of,chimpanzees in AIDS ...ific,justification," according to a paper released...nimals (ATLA). "An Assessment of the Role of,Chimp...ccine responses in,chimpanzees are not predictive ...zees, critical role and importance in AIDS vaccine...
Breaking Medicine Technology:CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Data Show Aerovance's Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 2Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 3Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection 4Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees 2Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 1Salugen to Present at Nutrition Capital Networks First In Person Investor Meeting 1154 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 1University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 3Prostate cancer more likely to return in blacks than whites but the disease is not more aggressive 3212 1Prostate cancer more likely to return in blacks than whites but the disease is not more aggressive 3212 2Fruit and vegetables health 3210 1
...fety of Gene Therapy in Lipoprotein Lipase,Deficie... 31, 2007 - Amsterdam Molecular,Therapeutics (AMT)...orted positive Phase I/II clinical trial results w...MT-011) in Complete,Lipoprotein Lipase (LPL) defic...erican Society of Gene Therapy (ASGT) in Seattle.,...
...rom XL880, Phase II data from XL999 studies,schedu...-, SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-F...ata from clinical trials of,the company,s investig...d at the 2007 American Society of Clinical Oncolog...1 to 5 in Chicago,Illinois. , , -- Data from t...
Other Medicine Technology:AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 2AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 3AMT Presents Positive Results of Phase I/II Study with Lead Product,at Annual Meeting of American Society of Gene Therapy 4Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: